Camphor and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Camphor (camphor) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include large intestinal obstruction among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Camphor and Dilaudid. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Camphor?

Camphor has active ingredients of camphor. eHealthMe is studying from 627 Camphor users. Check the latest studies of Camphor.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

On Jul, 25, 2026

20 people who take Camphor and Dilaudid together, and have interactions are studied.

What are the common drug interactions of Camphor and Dilaudid, by gender? *:

female:

Large intestinal obstruction
Nausea (feeling of having an urge to vomit)
Small intestinal perforation (hole in small intestine)
Vomiting
Colitis (inflammation of colon)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Death
Febrile neutropenia (fever with reduced white blood cells)
Fluid overload (too much fluid in the blood)
Lymphopenia (an abnormally low level of lymphocytes in the blood)

male:

Chronic kidney disease
Osteonecrosis (death of bone)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Proctitis (inflammation of the rectum and anus)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Blood creatinine increased
Bone density decreased
Emotional distress

What are the common drug interactions of Camphor and Dilaudid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Blood creatinine increased
Bone density decreased
Emotional distress
Hip arthroplasty
Renal impairment (severely reduced kidney function)
Tooth loss
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Death

50-59:

Colitis (inflammation of colon)

60+:

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Proctitis (inflammation of the rectum and anus)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

What are the existing conditions these people have? *

Constipation: 8 people, 40.00%
Rashes (redness): 8 people, 40.00%
Nausea And Vomiting: 8 people, 40.00%
Abdominal Pain: 6 people, 30.00%
Back Pain: 6 people, 30.00%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 6 people, 30.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 20.00%
Fever: 3 people, 15.00%
Renal Cell Carcinoma (a kidney cancer): 3 people, 15.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Camphor and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously